Aspirin lowers bile duct cancer risk
Regular aspirin use is associated with an approximately threefold reduction in risk for the three major subtypes of cholangiocarcinoma, results of a case-control study indicate. In a study comparing... (Source: Family Practice News)
Source: Family Practice News - May 3, 2016 Category: Primary Care Source Type: news

Medical News Today: Bile duct cancer risk may be reduced with aspirin use
The risk of bile duct cancer, or cholangiocarcinoma, was reduced by up to 3.6-fold for aspirin users in a new study, providing further evidence of the drug's anticancer effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 2, 2016 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Large placebo effect seen in trial of maralixibat for primary biliary cholangitis
BARCELONA – An international phase II trial with the investigational bile acid transporter inhibitor maralixibat chloride failed to meet its primary endpoint of reducing the weekly itch score to a... (Source: Family Practice News)
Source: Family Practice News - April 27, 2016 Category: Primary Care Source Type: news

Aspirin may help prevent bile duct cancer
(Wiley) Regular use of aspirin was linked with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2016 Category: Global & Universal Source Type: news

How vibrio cholera is attracted by bile revealed
A group of researchers has revealed their finding that the molecular mechanism that Vibrio cholerae, the etiological agent of cholera, is attracted by bile. This group has also successfully detected the ligand binding to the bacteria chemoreceptor in vivo for the first time. These results may significantly advance research on mechanism and control of V. cholerae. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 25, 2016 Category: Science Source Type: news

How Vibrio cholerae is attracted by bile revealed
(Osaka University) A group of researchers from Osaka University, Hosei University, and Nagoya University have revealed the molecular mechanism that Vibrio cholerae, the etiological agent of cholera, is attracted by bile. This group has also successfully detected the ligand binding to the bacteria chemoreceptor in vivo for the first time. These results may significantly advance research on mechanism and control of V. cholera. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 25, 2016 Category: Global & Universal Source Type: news

Aspirin May Lower Risk for Bile Duct CancerAspirin May Lower Risk for Bile Duct Cancer
Observational data show that low-dose aspirin users have reduced risk for bile duct cancer in all three subtypes of cholangiocarcinoma. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 22, 2016 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Study: Aspirin use may prevent bile duct cancer
Stephen FellerCLEVELAND, April 19 (UPI) -- Daily aspirin use can reduce risk for bile duct cancer, researchers at the Mayo Clinic report in a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2016 Category: Consumer Health News Source Type: news

Aspirin use may help prevent bile duct cancer, study finds
Aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, report scientists at the conclusion of their study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 19, 2016 Category: Science Source Type: news

Aspirin use may help prevent bile duct cancer, Mayo-led study finds
(Mayo Clinic) A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2016 Category: Global & Universal Source Type: news

Aspirin Use May Help Prevent Bile Duct Cancer
ROCHESTER, Minn. — A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology. “Our study found that individuals who took aspirin had a more than a two-and-a-half to three-and-a-half-fold lesser [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 18, 2016 Category: Databases & Libraries Source Type: news

Investigational treatment provides hope for some chronic liver disease sufferers
A new study provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterized by inflammation and scarring in the bile ducts of the liver and for which there are currently no medicines. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 16, 2016 Category: Science Source Type: news

Investigational treatment provides hope for some chronic liver disease sufferers
(European Association for the Study of the Liver) A new study presented today provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterized by inflammation and scarring in the bile ducts of the liver and for which there are currently no medicines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 16, 2016 Category: Infectious Diseases Source Type: news

Sharing Mayo Clinic: Outdoorsman Lives Life to the Fullest After Liver Transplant
Being diagnosed with bile duct cancer that eventually necessitated a liver transplant wasn't enough to keep Steve Woodford down for long. A South African native living in Utah, Steve is professional skydiving instructor, backpacker and canyon guide in Zion National Park. He has always lived on the edge with his active outdoors lifestyle. Getting sick [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2016 Category: Databases & Libraries Source Type: news

Liver brothers: Two lives linked by split-liver transplant
It is late in the evening on June 14, 2015. Kern Tyler and his wife Pasina Mazoka-Tyler sit in a waiting room at Boston Children’s Hospital, while their 11-month-old son Malambo Mazoka-Tyler, born with a life-threatening disease called biliary atresia, undergoes a liver transplant. To arrive at this moment, they have traveled vast distances, visited multiple hospitals, sought the advice and counsel of numerous doctors, packed all their belongings and moved more than 7000 miles from their home in Zambia, Africa, to Boston, Massachusetts. He had picked out what he wanted to wear, where he wanted to be buried, and he told ...
Source: Thrive, Children's Hospital Boston - April 4, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories biliary atresia cystic fibrosis Cystic Fibrosis Center end-stage liver disease Heung Bae Kim Khashayar Vakili liver failure Liver transplant Liver Transplant Program Rima Fawaz Split liver transplantation Source Type: news